Naloxone Market COVID19 Impact, Industry Outlook, Derive Growth, Size Report, Trend, Share, Revenue Forecast to 2028 | ADAPT Pharma, Inc., kaleo, Inc., Amphastar Pharmaceuticals


 

The opioid antagonist drug naloxone is used to treat opioid overdose. Opioids are analgesics that are commonly used to relieve chronic pain, but their non-medical usage is on the rise. Opioids cause euphoria in addition to pain relief, and as a result, opioid misuse is on the rise all over the world. According to the National Institute on Drug Usage, 130 persons die every day in the United States as a result of opioid abuse.

Naloxone is a drug that is used to reverse the effects of an opioid overdose. In the United States, the cost of prescription opioid misuse is more than US$ 78.5 billion per year, indicating a considerable economic impact and scope of opioid misuse. In 2017, over 1.7 million people in the United States suffered from an opioid-related substance use problem, and naloxone is presently the sole effective medicine for treating opioid overdoses.

The naloxone market is likely to grow as the occurrence of opioid overdoses rises. The rising prevalence of opioid drug usage in both the developed and developing worlds is predicted to propel the naloxone market forward. The use of opioids for chronic pain management is on the rise around the world, and as a result, non-medical opioid usage is on the rise as well, which is likely to fuel the expansion of the naloxone market.

The market is likely to grow further as people become more aware of the availability of naloxone for the treatment of opioid overdoses. When delivered, naloxone has a rapid beginning of therapeutic effect, which aids in patient compliance, propelling the naloxone market forward.

Patients' and healthcare professionals' compliance is predicted to increase as a result of easy-to-administer and measured-dose formulations, which will drive the naloxone market forward.

The naloxone market is predicted to rise as a result of a large number of clinical trials now underway for the development of innovative dosage forms for the treatment of opioid addiction. Healthcare professionals and advocacy groups are stepping up their efforts. The expansion of the naloxone market is predicted to be driven by non-profit organisations and the government's awareness of opioid abuse and the availability of treatment.

 

ADAPT Pharma, Inc., kaleo, Inc., Amphastar Pharmaceuticals, Inc., Pfizer Inc., Sandoz, SG Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., Samarth Life Sciences Pvt. Ltd., Somerset Therapeutics LLC, and others are among the major competitors in the global naloxone market.

Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more